Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.
Amino groups of batroxobin (Bothrops atrox thrombic protease) were modified with 2,4-bis(O-methoxypolyethylene glycol)-6-chloro-s-triazine (activated PEG2). The modified batroxobin had the reduced binding ability towards anti-batroxobin antibody but retained its enzymic activity in vitro and in vivo. Administration of modified batroxobin in which 29% of the total amino groups in the molecule had been modified, to beagle dogs preimmunized with native batroxobin gave rise to a marked reduction of the fibrinogen level in plasma, accompanied with an increased level of fibrinogen (fibrin) degradation products, FDP. On the other hand, no reduction of fibrinogen level was observed when native batroxobin instead of modified batroxobin was injected to immunized dogs.
D000818:Animals; D000906:Antibodies / Q000276:immunology; D000915:Antibody Affinity; D012103:Batroxobin / Q000276:immunology* / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D005340:Fibrinogen / Q000378:metabolism*; D007114:Immunization; D008297:Male; D010447:Peptide Hydrolases / Q000276:immunology*; D011092:Polyethylene Glycols; D013329:Structure-Activity Relationship
D000906:Antibodies; D011092:Polyethylene Glycols; C029761:2,4-bis(O-methoxypolyethylene glycol)-6-chloro-s-triazine; D005340:Fibrinogen; D010447:Peptide Hydrolases; D012103:Batroxobin